Shares of Edwards Lifesciences Corp. /zigman2/quotes/205745196/composite EW +0.12% sank 0.27% to $120.69 Thursday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index /zigman2/quotes/210599714/realtime SPX +0.30% falling 0.16% to 4,473.75 and Dow Jones Industrial Average /zigman2/quotes/210598065/realtime DJIA -0.02% falling 0.18% to 34,751.32. The stock's fall snapped a two-day winning streak. Edwards Lifesciences Corp. closed $2.58 below its 52-week high ($123.27), which the company achieved on September 8th.
The stock demonstrated a mixed performance when compared to some of its competitors Thursday, as Medtronic PLC /zigman2/quotes/206816578/composite MDT -0.11% fell 0.55% to $130.92, Boston Scientific Corp. /zigman2/quotes/203726728/composite BSX +0.90% fell 0.24% to $44.90, and ICU Medical Inc. /zigman2/quotes/208026181/composite ICUI -0.48% fell 0.33% to $243.08. Trading volume (1.6 M) remained 387,515 below its 50-day average volume of 2.0 M.